🗂️ Registry-based EuroTR score stratifies 1-year death after
🗂️ Registry-based EuroTR score stratifies 1-year death after
An AI-driven EuroTR risk score trained on a large real-world registry (N=1,826; derivation n=1,225, validation n=601) stratified 1-year mortality after tricuspid transcatheter edge-to-edge repair (T-TEER), separating low- vs high-risk patients (HR 4.26; 95% CI 2.71–6.67). Overall 1-year survival was 82.1% (95% CI 80.1%–84.2%), with similar performance across derivation and validation cohorts.
Why It Matters To Your Practice
T-TEER candidates often have advanced right-sided disease and competing comorbidities, making pre-procedure risk conversations and selection decisions high-stakes.
An externally validated, registry-based AI score may offer more individualized 1-year mortality estimates than relying on clinician gestalt or non–procedure-specific models.
Clinical Implications
Use EuroTR-style risk stratification to support shared decision-making (expected benefit vs risk) and to frame goals-of-care discussions before T-TEER.
In multidisciplinary valve conferences, a standardized score can help align thresholds for referral, intervention timing, and post-procedure surveillance intensity.
Consider risk tiering when planning peri-procedural optimization (volume status, renal function, anticoagulation strategy, and hemodynamic assessment).
Insights
The model was built on 18 clinical, lab, echo, and hemodynamic features using extreme gradient boosting—an example of “AI as a calculator” embedded in routine variables rather than novel sensors.
External validation (separate validation cohort) is a key differentiator from many single-center ML tools and improves the odds of transportability.
The output is best viewed as risk stratification (low vs high risk) to inform decisions—not as a stand-alone directive to treat or defer.
The Bottom Line
In EuroTR registry patients undergoing T-TEER, an AI-derived EuroTR score stratified 1-year mortality (HR 4.26) with overall 1-year survival ~82%.
Near-term impact for clinicians: better calibrated pre-procedure counseling and more consistent heart-team decision-making using routine data.